-
- The medicinal properties of the salicylates have been known since the 5th centuryAspirin Foundation: Salicylates
- Chemist Heinrich Dreser gave aspirin its name in 1899Opiods.com: Heinrich Dreser
- Aspirin first became available without a prescription in 1915Bayer: Aspirin without prescription
- In the 1980s aspirin was shown to have anti-clotting effectsBiology, ualberta: Anti-clotting effects
- Long term use of aspirin my reduce the risk of some types of cancerCNN: Aspirin Study
- Aspirin may cause problems with the stomach and kidneysEmedicine: Aspirin toxicity
- It is estimated that 50,000 metric tons of aspirin are consumed worldwide each yearTransnational Institute: Drug Policy Briefing -- June 2006PDF
-
-
Aspirin is the first of the NSAIDs that was discovered, and is one of several salicylate drugs. Salicylates have been known to be effective since the 5th century, when Hippocrates first began to prescribe the willow bark rich in salicin to patient for the treatment of minor pain and fever. Today, aspirin is still prescribed for the relief of minor pain, fever and also has anti-inflammatory properties. It is also sometimes prescribed to prevent heart attacks because it provides a blood-thinning effect.
-
-
-
Aspirin Questions
If you are allergic to aspirin, do you have a reaction when using personal care products with salicylates? 3 AnswersI am not a doctor, but from what I have read below, it really depends on the type of allergic reaction that you have and how sensitive you are. Some people are... read more
OPEN THREAD: Asprin can help colorectal cancer patients 3 AnswersStudies did show that there are benefits to taking aspirin after diagnosis of Colorectal Cancer. Apparently the aspirin can inhibit Cyclooxygenase (COX-2), a ch... read more
Does anyone have a cure for a headache that withstands Aspirin, a nap and keeps on going and going? 2 AnswersYour headache could be caused by one of several things. WebMD has a great page that lists common types of headaches as well as their symptoms. It's possible to... read more

